Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study

Li,Xiao‑Yu; Xu,Li; Li,Hong‑Li; Du,Jing; Liu,Xue‑Song; Li,Feng‑Hua

doi:10.3892/mmr.2017.8351

Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study

Authors:
- Xiao‑Yu Li
- Li Xu
- Hong‑Li Li
- Jing Du
- Xue‑Song Liu
- Feng‑Hua Li
View Affiliations

Affiliations: Department of Ultrasound, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China
Published online on: December 27, 2017 https://doi.org/10.3892/mmr.2017.8351
Pages: 3763-3768

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to prepare and characterize an Au-poly(lactic-co-glycolic) acid (PLGA) complex, surfaced with gold nanoparticles (GNPs), and to assess its use as an ultrasound contrast agent for in vitro imaging. PLGA nanoparticles (NPs) were prepared by a modified double‑emulsion solvent evaporation method. GNPs were prepared via reduction with sodium citrate. Au‑PLGA complexes were created through the binding of polyethylene glycosylated GNPs to the surface of PLGA NPs. Various physical characteristics of PLGA NPs, GNPs and Au‑PLGA complexes, including morphology, size, dispersion, ζ potential and stability were observed and measured. The study of the in vitro imaging capability of the Au‑PLGA complex was conducted by setting multi‑parameter imaging conditions. The average sizes of PLGA NPs, GNPs and the Au‑PLGA complex were 144.5±30.28, 21.42±1.56 and 359.4±67.94 nm, respectively. Transmission electron microscopy (TEM) revealed that PLGA NPs and GNPs were spherically shaped, but GNPs had smooth surface while PLGA NPs had a capsular morphology with a wrinkled surface and large voids. The maximum absorption peak of 20 nm GNPs was 508 nm while that of the Au‑PLGA complex was 515 nm on an ultraviolet‑visible absorption spectrum curve. The results of TEM and the redshift spectrum demonstrated that GNPs successfully bound to the surface of the PLGA NPs. The complex demonstrated good stability and its size changed little over time. In vitro imaging experiments revealed that the Au‑PLGA complex had a good imaging ability. The present study demonstrated that the Au‑PLGA complex is a promising novel ultrasound contrast agent.

View Figures

View References

1	Khlebtsov N, Bogatyrev V, Dykman L, Khlebtsov B, Staroverov S, Shirokov A, Matora L, Khanadeev V, Pylaev T, Tsyganova N and Terentyuk G: Analytical and theranostic applications of gold nanoparticles and multifunctional nanocomposites. Theranostics. 3:167–180. 2013. View Article : Google Scholar : PubMed/NCBI
2	Jain S, Hirst DG and O'sullivan JM: Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 85:101–113. 2012. View Article : Google Scholar : PubMed/NCBI
3	Kim BY, Rutka JT and Chan WC: Nanomedicine. N Engl J Med. 363:2434–2443. 2010. View Article : Google Scholar : PubMed/NCBI
4	Yeh YC, Creran B and Rotello VM: Gold nanoparticles: Preparation, properties, and applications in bionanotechnology. Nanoscale. 4:1871–1880. 2012. View Article : Google Scholar : PubMed/NCBI
5	Song KH, Kim C, Maslov K and Wang LV: Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur J Radiol. 70:227–231. 2009. View Article : Google Scholar : PubMed/NCBI
6	Néstor MM, Kei NP, Guadalupe NA, Elisa ME, Adriana GQ and David QG: Preparation and in vitro evaluation of poly(D, L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging. Ultrasonics. 51:839–845. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kohl Y, Kaiser C, Bost W, Stracke F, Fournelle M, Wischke C, Thielecke H, Lendlein A, Kratz K and Lemor R: Preparation and biological evaluation of multifunctional PLGA-nanoparticles designed for photoacoustic imaging. Nanomedicine. 7:228–237. 2011. View Article : Google Scholar : PubMed/NCBI
8	Xu JS, Huang J, Qin R, Hinkle GH, Povoski SP, Martin EW and Xu RX: Synthesizing and binding dual-mode poly(lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials. 31:1716–1722. 2010. View Article : Google Scholar : PubMed/NCBI
9	Ke H, Wang J, Dai Z, Jin Y, Qu E, Xing Z, Guo C, Yue X and Liu J: Gold-nanoshelled microcapsules: A theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Ed Engl. 50:3017–3021. 2011. View Article : Google Scholar : PubMed/NCBI
10	Xu RX, Huang J, Xu JS, Sun D, Hinkle GH, Martin EW and Povoski SP: Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opts. 14:0340202009. View Article : Google Scholar
11	Frens G: Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature. 241:20–22. 1973.
12	Horisberger M and Rosset J: Colloidal gold, a useful marker for transmission and scanning electron microscopy. J Histochem Cytochem. 25:295–305. 1977. View Article : Google Scholar : PubMed/NCBI
13	Cózar-Bernal MJ, Holgado MA, Arias JL, Muñoz-Rubio I, Martín-Banderas L, Alvarez-Fuentes J and Fernández-Arévalo M: Insulin-loaded PLGA microparticles: Flow focusing versus double emulsion/solvent evaporation. J Microencapsul. 28:430–441. 2011. View Article : Google Scholar : PubMed/NCBI
14	Shive MS and Anderson JM: Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 28:5–24. 1997. View Article : Google Scholar : PubMed/NCBI
15	Wang CW, Yang SP, Hu H, Du J and Li FH: Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent. Mol Med Rep. 11:1885–1890. 2015. View Article : Google Scholar : PubMed/NCBI
16	Cho SH, Kim JY and Kim JD: Dynamic surface tension of stable air-filled microbubbles prepared by freeze-drying a solution of lipid/surfactant mixture. Colloids and Surfaces A Physicochemical and Engineering Aspects. 284–285, 1-457. 2006.
17	Ma XY, Pan GM, Lu Z, Hu JS, Bei JZ, Jia JH and Wang SG: Preliminary study of oral polylactide microcapsulated insulin in vitro and in vivo. Diabetes Obes Metab. 2:243–250. 2000. View Article : Google Scholar : PubMed/NCBI
18	Kumari A, Yadav SK and Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 75:1–18. 2010. View Article : Google Scholar : PubMed/NCBI
19	Piñón-Segundo E, Nava-Arzaluz MG and Lechuga-Ballesteros D: Pharmaceutical polymeric nanoparticles prepared by the double emulsion-solvent evaporation technique. Recent Pat Drug Deliv Formul. 6:224–235. 2012. View Article : Google Scholar : PubMed/NCBI
20	Li XY, Yang ZL and Zhou HG: Studying the absorption spectrum properties of the gold nanosphere-The effect of the size on the absorption spectra of the anoparticles. J Zhangzhou Teachers Coll (Nat Sci). 17:31–34. 2004.
21	Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP and Jain RK: Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 55:3752–3756. 1995.PubMed/NCBI
22	Koo OM, Rubinstein I and Onyuksel H: Role of nanotechnology in targeted drug delivery and imaging: A concise review. Nanomedicine. 1:193–212. 2005. View Article : Google Scholar : PubMed/NCBI
23	Panchapakesan B and Wickstrom E: Nanotechnology for sensing, imaging, and treating cancer. Surg Oncol Clin N Am. 16:293–305. 2007. View Article : Google Scholar : PubMed/NCBI